Drugs for Neglected Diseases initiative

🎨 Did you know the colour of a tablet actually really matters? It’s not just about appearance 👉 colour plays an important role in how medicines are used and developed. #DrugDevelopment #GlobalHealth #ScienceExplained

@MahidolU, @fiocruz, @ufmg, @THSTIFaridabad, @KKMPutrajaya, @sanjayssarin

🤝 Tomorrow, the Dengue Alliance will convene in India for its 6th Joint Steering Committee Meeting to strengthen collaboration, accelerate research, and advance efforts to close the dengue treatment gap. Stay tuned for updates on the meeting!

マイセトーマは、アフリカをはじめとする蔓延地域のコミュニティで人々の生活を今なお深く蝕む、顧みられない熱帯病です。 朝日新聞の詳報では、患者の現実、診断・治療のギャップ、そしてDNDiとパートナーによる取り組みが紹介されています。@asahi 🔗 x.gd/B4nMj

#Mycetoma, an NTD affecting communities across endemic regions in Africa and beyond, continues to devastate lives. An in-depth report by @asahi highlights patients’ realities, gaps in diagnosis & treatment, & ongoing efforts by DNDi and partners. 🔗 x.gd/B4nMj

No #DiaMundialDaDoençaDeChagas, MSF e @DNDi se unem para reforçar: a doença pode ser tratada e, com diagnóstico precoce, curada. Na gestação, a transmissão pode ocorrer entre mãe e bebê. Com o cuidado certo no momento certo, as chances de cura são altas. Saiba mais🧵⬇️ 1/5

New call under the Global Coalition on Neglected Diseases🦟 First focus➡️dengue, a growing threat driven by climate change. This means better preparedness, faster treatments and stronger global cooperation. 📅 Join the webinar on 15 April. More info🔗 globalcoalitionforlocalproduction.org/projects/

Twenty years ago, a doctor choosing between arsenic and death had no better options. Doctors now have a safe and effective oral treatment for sleeping sickness. I share a story of what public health can do. tomfrieden.substack.com/p/from-arsenic…

€50 million to boost R&D to strengthen the global fight against antimicrobial resistance & neglected diseases. Through DG #HERA, the @EU_Commission supports new treatments, from research to patients, strengthening preparedness against health threats. 🔗👉link.europa.eu/cBcNvp

The global spread of dengue is accelerating & response efforts must too! At the #OneHealth summit, experts shared their perspectives on how One Health, partnerships, & research & innovation can close critical gaps in dengue prevention, treatment & care 👇 youtube.com/watch?v=ZHjLY0…

Honored to join the One Health Summit side event on dengue hosted by @PasteurNetwork, @fiocruz, and @DNDi. #Dengue 🦟 is no longer only a tropical disease — it reflects how environmental change is reshaping public health risks globally.

🌎🦟Today at the International One Health Summit in Lyon, hosted by the Government of France, we’re joining leaders from @AFD_France, @francediplo, @ec_hera / @EU_Commission, to discuss why accelerating the development of dengue treatments is more urgent than ever.

📢Reminder Join us for a #dengue side event to explore: 🔬 Integrated surveillance and data-driven decision-making 💊 R&D for new diagnostics, vaccines, and treatments 🤝 Regional cooperation and equitable access to health technologies Info & registration👉community.pasteur-network.org/events/208484

@CombatNTDs Thanks for sharing!

Developing life-saving pills? It's about making complex science look like a plain white tablet. 💊🧐 Dr. Stephen Robinson of @DNDi breaks down the fascinating science of turning complex molecules into affordable medicine bit.ly/4sIj8Uz

A new study in @BMJPublicHealth shows current models predicting outcomes from visceral leishmaniasis are outdated, at high risk of bias, & miss regions like South Asia. None predict relapse or PKDL, only death. The authors urge caution when using them. doi.org/10.1136/bmjph-…

As a trusted steward of our financial integrity, the Board Treasurer helps ensure that DNDi remains accountable, sustainable, and equipped to deliver on our mission. 📆 Deadline: 27 April 👉 Details & how to apply: dndi.org/news/2026/dndi… 📣 Help us spread the word!

When Jaqueline was diagnosed with cutaneous #leishmaniasis at age 10, she endured painful injections & walked 13k to receive treatment at the health unit in Bahia, Brazil. Our goal is to develop a new generation of all-oral medicines that make treatment easier for patients.

MedChemica, Diamond, CMD & DNDi are partners in the ASAP consortium, an open-science project aimed at discovering & developing new medicines against viruses of pandemic potential, including coronaviruses & dengue virus. More about ASAP: dndi.org/research-devel… (3/3)

‘Our partners @DiamondLightSou & @CmdOxford are analyzing the molecular structures of around 10 new compounds most weeks. We still have a lot to do, but this is clearly the way to tackle dengue and deliver promising new drug candidates that we can advance to the clinic.' (2/3)

'Every two weeks we now generate more lead‑optimization structural data on #dengue than we did in the previous two decades combined. The pace of the ASAP open-source project is astounding,' said @griffen_ed, technical director @MedChemica . (1/3)